Medicover AB (OTCPK:MCVEY)
$ 16.55 0 (0%) Market Cap: 2.48 Bil Enterprise Value: 3.62 Bil PE Ratio: 119.73 PB Ratio: 4.66 GF Score: 72/100

Q2 2024 Medicover AB Earnings Call Transcript

Jul 25, 2024 / 07:30AM GMT
Release Date Price: $16.55
Fredrik Ragmark
Medicover AB - Chief Executive Officer, Director

So good morning, everyone. Welcome to our second-quarter 2024 report, and welcome to you all. Our summary slide and our headline continued strong organic growth and cash generation. I think this is a very good quarter. We had a good first-quarter in the year and we follow up with an equally strong and solid second-quarter.

You are used to us growing, but nevertheless, 20% top-line growth or which share it had over 16% organic is significant considering the size of the company and our base. Importantly, this is solid across both divisions and within the divisions across our different businesses, there's nothing individual that stands out. Poland has been strong for a long time. Poland remains strong, and we expect that continue going forward.

We had continued good member intake in our corporate business, and we equally had very strong laboratory test growth were actually back on pre pandemic organic volume growth levels in diagnostics, which I think is a surprise to some of you. And it's a very good sign again, that's

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot